Literature DB >> 6414694

The development of mesna for regional detoxification.

N Brock, J Pohl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6414694     DOI： 10.1016/s0305-7372(83)80005-x

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  18 in total

1.  Continuous IV infusion of MESNA can prevent hemorrhagic cystitis in HSCT and retain MESNA concentration in urine.

Authors:  Q Jiang; H Huang; Q Liu; J Sun; H Zhou; Z Fan; Y Zhang; F Huang; Y Chai; D Xu; Y Lu; Q Wei; G Yu; X Li; M Dai; N Xu; D Zhou; H Zhao; K Shen; Q Mai; Y Zhou; F Meng
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

2.  Tubular nephrotoxicity during long-term ifosfamide and mesna therapy.

Authors:  M P Goren; C B Pratt; M J Viar
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent.

Authors:  O Tofanetti; E Cavalletti; A Besati; G Pratesi; G Pezzoni; F Zunino
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  Benefits of Preventive Administration of Chlorella sp. on Visceral Pain and Cystitis Induced by a Single Administration of Cyclophosphamide in Female Wistar Rat.

Authors:  Sophie Hidalgo-Lucas; Pascale Rozan; Laetitia Guérin-Deremaux; Blandine Baert; Nicolas Violle; Marie-Hélène Saniez-Degrave; Jean-François Bisson
Journal:  J Med Food       Date:  2016-05       Impact factor: 2.786

5.  Interleukin-4 modulates the inflammatory response in ifosfamide-induced hemorrhagic cystitis.

Authors:  Francisco Yuri Bulcão Macedo; Lívia Talita Cajaseiras Mourão; Helano Carioca Freitas; Roberto C P Lima; Deysi Viviana Tenazoa Wong; Reinaldo Barreto Oriá; Mariana L Vale; Gerly Anne Casto Brito; Fernando Q Cunha; Ronaldo A Ribeiro
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

6.  Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma.

Authors:  T E Elliott; J C Buckner; T L Cascino; R Levitt; J R O'Fallon; B W Scheithauer
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

7.  Inducible nitric oxide synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats.

Authors:  Sukru Oter; Ahmet Korkmaz; Emin Oztas; Ibrahim Yildirim; Turgut Topal; Hayati Bilgic
Journal:  Urol Res       Date:  2004-01-31

8.  Does 2-mercaptoethane sulphonate (mesna) prevent cyclophosphamide and azathioprine induced immunosuppression? In vitro studies.

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

9.  Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin.

Authors:  T Wagner; B Kreft; G Bohlmann; G Schwieder
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

10.  Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases.

Authors:  Sean S Davies; Linda S Zhang
Journal:  Curr Pharmacol Rep       Date:  2017-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.